The current financial score of Teladoc Health Inc is 6.90. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 606.93M, representing a year-over-year decrease of 3.95%, while its net profit experienced a year-over-year decrease of 19.13%.
The current valuation score of Teladoc Health Inc is 8.71. Its current P/E ratio is -6.42, which is -95.90% below the recent high of -0.26 and -156.16% above the recent low of -16.45.
The current earnings forecast score of Teladoc Health Inc is 6.64. The average price target is 7.63, with a high of 10.50 and a low of 5.50.
The current price momentum score of Teladoc Health Inc is 3.34. Currently, the stock price is trading between the resistance level at 6.74 and the support level at 5.79, making it suitable for range-bound swing trading.
The current institutional shareholding score of Teladoc Health Inc is 7.00. The latest institutional shareholding proportion is 86.37%, representing a quarter-over-quarter increase of 20.46%.
The current risk assessment score of Teladoc Health Inc is 5.30. The company's beta value is 1.99. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.